Dr Sarah Auburn is a molecular biologist with expertise in the genetic and genomic epidemiology of malaria. Her current research focus entails utilizing information on the genetic make-up of malaria parasites to gain insights into the biological mechanisms underlying antimalarial drug resistance, and to monitor transmission dynamics within and across borders. She holds a Senior Research Officer post at Menzies School of Health Research, Darwin, Australia, where she leads the genetic and genomic studies on Plasmodium vivax. She is also affiliated with the UK MRC Centre for Genomics and Global Health, supporting access to genomic technologies for country partners in the Asia Pacific Malaria Elimination Network.Related Projects
Related Publications
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- An open access platform for comparative analysis of short tandem repeat genotyping data in Plasmodium vivax populations
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax in Ethiopia: a randomized controlled trial
- Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination
- Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: an open-label randomised controlled trial
- Genomic analysis of local variation and recent evolution in Plasmodium vivax
- Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite Mechanisms
- Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand
- Genomic epidemiology of artemisinin resistant malaria
- Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
- Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia–Pacific region
- Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
- Plasmodium malariae and ovale genomes provide insights into malaria parasite evolution
- Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
- The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools